These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24751611)

  • 1. Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries.
    Abdel-Aziz AK; Shouman S; El-Demerdash E; Elgendy M; Abdel-Naim AB
    Chem Biol Interact; 2014 Jun; 217():28-40. PubMed ID: 24751611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Ping SY; Wu CL; Yu DS
    Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries.
    Abdel-Aziz AK; Mantawy EM; Said RS; Helwa R
    Exp Neurol; 2016 Sep; 283(Pt A):129-41. PubMed ID: 27288242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
    Suddek GM
    Cancer Chemother Pharmacol; 2011 May; 67(5):1035-44. PubMed ID: 20652569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.
    Lopergolo A; Nicolini V; Favini E; Dal Bo L; Tortoreto M; Cominetti D; Folini M; Perego P; Castiglioni V; Scanziani E; Borrello MG; Zaffaroni N; Cassinelli G; Lanzi C
    J Clin Endocrinol Metab; 2014 Feb; 99(2):498-509. PubMed ID: 24276455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
    Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
    Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
    Wu CL; Ping SY; Yu CP; Yu DS
    Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
    Saraswati S; Agrawal SS; Alhaider AA
    Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism.
    Wiedmer T; Blank A; Pantasis S; Normand L; Bill R; Krebs P; Tschan MP; Marinoni I; Perren A
    Mol Cancer Ther; 2017 Nov; 16(11):2502-2515. PubMed ID: 28729403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
    Agrawal SS; Saraswati S; Mathur R; Pandey M
    Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
    Mei L; Chen Y; Wang Z; Wang J; Wan J; Yu C; Liu X; Li W
    Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models.
    Gao H; Jiang Q; Han Y; Peng J; Wang C
    Cell Biochem Biophys; 2015 Mar; 71(2):757-64. PubMed ID: 25260394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma.
    Huynh H; Ngo VC; Choo SP; Poon D; Koong HN; Thng CH; Toh HC; Zheng L; Ong LC; Jin Y; Song IC; Chang AP; Ong HS; Chung AY; Chow PK; Soo KC
    Curr Cancer Drug Targets; 2009 Sep; 9(6):738-47. PubMed ID: 19754358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
    Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
    Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction.
    Kleibeuker EA; Ten Hooven MA; Castricum KC; Honeywell R; Griffioen AW; Verheul HM; Slotman BJ; Thijssen VL
    Cancer Med; 2015 Jul; 4(7):1003-15. PubMed ID: 25828633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib Induces NK-κB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma Cells.
    Huang YX; Chen XT; Guo KY; Li YH; Wu BY; Song CY; He YJ
    J Immunother; 2017 Jun; 40(5):164-174. PubMed ID: 28452850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells.
    Diaz R; Nguewa PA; Redrado M; Manrique I; Calvo A
    Prostate; 2015 Aug; 75(11):1137-49. PubMed ID: 25893276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
    Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
    Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model.
    Sonpavde G; Jian W; Liu H; Wu MF; Shen SS; Lerner SP
    Urol Oncol; 2009; 27(4):391-9. PubMed ID: 18534874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells.
    Zhao Y; Xue T; Yang X; Zhu H; Ding X; Lou L; Lu W; Yang B; He Q
    Toxicol Appl Pharmacol; 2010 Oct; 248(1):20-7. PubMed ID: 20637791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.